Facebook
Twitter
Telegram
Report an ErrorPliant Therapeutics Financial Statements 2011-2024 | PLRX
Annual Financial Statements Pliant Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.01 B | 1.19 B | 322 M | 872 M | - | - | - | - | - | - | - | - | - |
Shares |
58.7 M | 42 M | 35.8 M | 35.4 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
17.2 | 28.3 | 8.97 | 33.1 | - | - | - | - | - | - | - | - | - |
Net Income |
-161 M | -123 M | -97.3 M | -41.5 M | -631 K | -30.3 M | - | - | - | - | - | - | - |
Revenue |
1.58 M | 9.68 M | 7.57 M | 41.8 M | 57.1 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 41.8 K | - | - | - | - | - | - | - | - | - |
Operating Income |
-184 M | -127 M | -97.5 M | -41.6 M | -1.23 M | - | - | - | - | - | - | - | - |
Interest Expense |
1.27 M | 791 K | - | -366 K | -216 K | - | - | - | - | - | - | - | - |
EBITDA |
-182 M | -125 M | -96 M | -40.3 M | -118 K | -30.2 M | - | - | - | - | - | - | - |
Operating Expenses |
186 M | 137 M | 105 M | 83.5 M | 58.3 M | 30.9 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
57.9 M | 39.9 M | 27.6 M | 17.3 M | 10.9 M | 6.5 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Pliant Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
60.2 M | 59.9 M | 59.7 M | 59.2 M | 56.1 M | 48.9 M | 46.8 M | 36.2 M | 36.1 M | 36.1 M | 35.9 M | 35.7 M | 35.6 M | 35.6 M | 35.4 M | 12.3 M | 1.9 M | 1.85 M | 1.71 M | 1.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-47 M | - | -41.5 M | -41.2 M | -37.5 M | - | -30.6 M | -29.5 M | -28.1 M | - | -27 M | -22.8 M | -22.9 M | - | -16.5 M | -17 M | 11 M | - | -13.3 M | -15.5 M | -14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | 248 K | 1.33 M | - | 1.48 M | 4.99 M | 1.25 M | - | 1.61 M | 1.79 M | 2.17 M | - | 4.81 M | 3.6 M | 28.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-52.4 M | - | -47.7 M | -47.3 M | -42.1 M | - | -31.9 M | -29.6 M | -28.2 M | - | -27.1 M | -22.9 M | -22.9 M | - | -16.7 M | -17 M | 11 M | - | -13.4 M | -15.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
445 K | - | 317 K | 319 K | 311 K | - | 301 K | 173 K | - | - | - | - | - | - | 55 K | -136 K | - | - | -41 K | -21 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-51.9 M | - | -47.2 M | -46.9 M | -41.6 M | - | -31.4 M | -29.2 M | -27.8 M | - | -26.7 M | -22.5 M | -22.6 M | - | -16.4 M | -16.7 M | 11.3 M | - | -13.1 M | -15.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
52.4 M | - | 47.7 M | 47.6 M | 43.4 M | - | 33.4 M | 34.6 M | 29.5 M | - | 28.7 M | 24.7 M | 25.1 M | - | 21.5 M | 20.6 M | 17.9 M | - | 13.4 M | 15.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
15.2 M | - | 15.3 M | 14.6 M | 14.2 M | - | 8.82 M | 8.3 M | 8.58 M | - | 7.67 M | 5.48 M | 6.57 M | - | 4.59 M | 3.04 M | 4.01 M | - | 2.58 M | 2.64 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency